Clinical relevance of changes in bone metabolism in inflammatory bowel disease

Research output: Contribution to journalEditorial

14 Citations (Scopus)


Low bone mineral density is an established, frequent, but often neglected complication in patients with inflammatory bowel disease (IBD). Data regarding the diagnosis, therapy and follow-up of low bone mass in IBD has been partially extrapolated from postmenopausal osteoporosis; however, the pathophysiology of bone loss is altered in young patients with IBD. Fracture, a disabling complication, is the most important clinical outcome of low bone mass. Estimation of fracture risk in IBD is difficult. Numerous risk factors have to be considered, and these factors should be weighed properly to help in the identification of the appropriate patients for screening. In this editorial, the authors aim to highlight the most important clinical aspects of the epidemiology, prevention, diagnosis and treatment of IBD-related bone loss.

Original languageEnglish
Pages (from-to)5536-5542
Number of pages7
JournalWorld journal of gastroenterology
Issue number44
Publication statusPublished - Nov 28 2010


  • Crohn's disease
  • Inflammatory bowel disease
  • Osteopenia
  • Osteoporosis
  • Prevention

ASJC Scopus subject areas

  • Gastroenterology

Fingerprint Dive into the research topics of 'Clinical relevance of changes in bone metabolism in inflammatory bowel disease'. Together they form a unique fingerprint.

  • Cite this